Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer

Published:2021-05 Issue:5 Volume:7 Page:410-429
ISSN:2405-8033
Container-title:Trends in Cancer
language:en
Short-container-title:Trends in Cancer

Author:

Nokin Marie-Julie,Ambrogio Chiara,Nadal Ernest,Santamaria David

Funder

Centres de Recerca de Catalunya

Giovanni Armenise-Harvard Foundation

Institut National Du Cancer

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference207 articles.

1. Large-scale screening for somatic mutations in lung cancer;Rosell;Lancet,2016

2. Novel drugs targeting EGFR and HER2 exon 20 mutations in metastatic NSCLC;Baraibar;Crit. Rev. Oncol. Hematol.,2020

3. Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial;Planchard;Lancet Oncol.,2016

4. Efficacy of selpercatinib in RET fusion-positive non-small-cell lung cancer;Drilon;N. Engl. J. Med.,2020

5. Registrational dataset from the phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET fusion+ non-small cell lung cancer (NSCLC);Gainor;J. Clin. Oncol.,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma;Cell Reports Medicine;2024-08

2. Association of PD‐L1 expression with driver gene mutations and clinicopathological characteristics in non‐small cell lung cancer: A real‐world study of 10 441 patients;Thoracic Cancer;2024-03-08

3. Novel RAF‐directed approaches to overcome current clinical limits and block the RAS/RAF node;Molecular Oncology;2024-02-16

4. Therapeutic strategy using novel RET/YES1 dual-target inhibitor in lung cancer;Biomedicine & Pharmacotherapy;2024-02

5. Ultra-rapid Idylla™ EGFR mutation screening followed by next-generation sequencing: An integrated solution to molecular diagnosis of non-small cell lung cancer;Frontiers in Oncology;2023-03-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3